These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7327456

  • 1. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T, Fukuchi I, Ego H, Yamamura M, Kudo Y, Ishida R.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [Abstract] [Full Text] [Related]

  • 2. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
    Ochiai T, Yamamura M, Kudo Y, Ishida R.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
    [Abstract] [Full Text] [Related]

  • 3. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological studies on oxatomide: (6) Effect on the peripheral organs].
    Ohmori K, Ishii H, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):79-104. PubMed ID: 6133821
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 Jan; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 6. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 7. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 8. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [Abstract] [Full Text] [Related]

  • 9. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]

  • 10. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985 Dec; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 11. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 12. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A.
    Arzneimittelforschung; 1981 Oct; 31(4):707-15. PubMed ID: 6113834
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity.
    Ochiai T, Ishida R.
    Jpn J Pharmacol; 1982 Jun; 32(3):427-38. PubMed ID: 7109348
    [Abstract] [Full Text] [Related]

  • 16. [Effects of afloqualone, a new centrally acting muscle relaxant, on DRL response and CER in rats (author's transl)].
    Yamamura M, Ochiai T, Ishida R.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):381-92. PubMed ID: 6120127
    [Abstract] [Full Text] [Related]

  • 17. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
    Hirotsu I, Kihara T, Hattori Y, Hatta M, Hirose N, Ishihara T, Satoh F.
    Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K, Kimura T, Saeki I, Tabata R, Yamazaki S, Eguchi I, Hanazuka M, Horii D, Munt PL, Davis AS.
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [Abstract] [Full Text] [Related]

  • 19. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
    Arisawa H, Fukui K, Fujise N, Masunaga H.
    Arzneimittelforschung; 2002 Jun; 52(2):81-8. PubMed ID: 11878203
    [Abstract] [Full Text] [Related]

  • 20. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K, Hiraiwa T, Terashima N, Arai H, Ono S, Hashiba K, Maekawa M, Kitamura K, Nakada Y, Mori Y.
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.